What the heck is up with this chart man? They just got a deal going with Novo Nordisk, which is pretty interesting.
[https://www.pharmaceutical-technology.com/news/novo-nordisk-signs-pact-with-vivani-for-long-lasting-semaglutide-implant/](https://www.pharmaceutical-technology.com/news/novo-nordisk-signs-pact-with-vivani-for-long-lasting-semaglutide-implant/)